Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.
Read the guideAn independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.
View the provider overviewOverview & reviewsPrimers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.
View all Learn articlesWhat compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.
Last updated: June 2026
We read what readers send us — corrections especially. Use the address that fits your message and we'll route it to the right person.
Story tips, questions about our coverage, and factual corrections go to [email protected]. If you're flagging an error, a link to the page and the specific claim helps us check it against the source quickly. We correct mistakes and note material corrections on the affected page — see our corrections process.
For interview requests, data citations, or questions about our research, write to [email protected].
To access, correct, or delete information we hold about you, contact [email protected]. Details on what we collect are in our privacy policy.
We're an editorial publication, not a clinic or pharmacy. We can't provide medical advice, prescribe, dispense, or comment on your personal treatment. For anything clinical, consult a licensed healthcare provider familiar with your medical history.
Editorial note: this page is for informational purposes and does not constitute medical advice.